Clinical Research Clinical Trial and Pharmacogenomics
A new cancer-drug distribution system that aims to cut drug costs for community oncology practices around the country is being launched by OneOncology Inc., of Orlando, Fla., which started its Web-based system In a challenge to the status quo of the drug-distribution business, OneOncology plans to conduct periodic online “reverse auctions.” Wholesale-drug distributors would bid [...]
Filed under: cancer, open source in biotechnoligy | Leave a Comment »
Scientists from the Lucile Packard Children’s Hospital and the Stanford University School of Medicine have identified a pattern of gene expression shared by a small group of patients who beat the odds and remained healthy for years without medication, after undergoing Organ transplant. The findings made by Minnie Sarwal, MD, PhD, a pediatric nephrologist at [...]
Filed under: biodefense, bioinformatics blog, cancer, clinical genomics, DNA, DNA diagnostics, gene expression, gene therapy, genetic medicine, genetics, Genomics, microaray blog, Pharmacogenomics, transgenomics | 9 Comments »
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online. Researchers developed and validated a new genomic microarray test that identifies whether a [...]
Filed under: Affymetrix, bioinformatics, bioinformatics blog, bioinformatics software, cancer, cancer microarray, clinical diagnostics, clinical microarray, Clinical microarrays, custom microarray, DNA, DNA microarray, drug development, drug discoverry, drug resistance, gene expression, genetics, genotyping, microaray blog, microarray, microarray analysis, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics | 3 Comments »
What makes you different from everyone else on the planet may have less to do with the spelling of your genetic code than with a scattering of chemical “tags” that, like censor’s marks, render some of your genes unreadable.The code itself, after all, is 99.9 percent identical in all of us, so these peripheral elements [...]
Filed under: bioinformatics, cancer, clinical diagnostics, clinical microarray, custom microarray, DNA microarray, drug discoverry, epigenetics, gene expression, genetics, genotyping, microarray, personalized medicine, Pharmacogenomics | Leave a Comment »
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online. Researchers developed and validated a new genomic microarray test that identifies whether a [...]
Filed under: Affymetrix, bioinformatics, cancer, cancer microarray, clinical diagnostics, clinical microarray, custom microarray, drug development, drug discoverry, gene expression, genetics, genotyping, Hormone replacement and Genetics, hormone replacement therapy, microarray, microarray for clinical diagnostics, Pharmacogenomics | Leave a Comment »
